{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T11:39:35Z","timestamp":1784893175489,"version":"3.55.0"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2023,5,29]],"date-time":"2023-05-29T00:00:00Z","timestamp":1685318400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,5,29]],"date-time":"2023-05-29T00:00:00Z","timestamp":1685318400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000925","name":"Department of Health | National Health and Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006492","name":"Division of Intramural Research, National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006492","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Immunol"],"published-print":{"date-parts":[[2023,6]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>High-risk groups, including Indigenous people, are at risk of severe COVID-19. Here we found that Australian First Nations peoples elicit effective immune responses to COVID-19 BNT162b2 vaccination, including neutralizing antibodies, receptor-binding domain (RBD) antibodies, SARS-CoV-2 spike-specific B cells, and CD4<jats:sup>+<\/jats:sup> and CD8<jats:sup>+<\/jats:sup> T cells. In First Nations participants, RBD IgG antibody titers were correlated with body mass index and negatively correlated with age. Reduced RBD antibodies, spike-specific B cells and follicular helper T cells were found in vaccinated participants with chronic conditions (diabetes, renal disease) and were strongly associated with altered glycosylation of IgG and increased interleukin-18 levels in the plasma. These immune perturbations were also found in non-Indigenous people with comorbidities, indicating that they were related to comorbidities rather than ethnicity. However, our study is of a great importance to First Nations peoples who have disproportionate rates of chronic comorbidities and provides evidence of robust immune responses after COVID-19 vaccination in Indigenous people.<\/jats:p>","DOI":"10.1038\/s41590-023-01508-y","type":"journal-article","created":{"date-parts":[[2023,5,29]],"date-time":"2023-05-29T12:02:12Z","timestamp":1685361732000},"page":"966-978","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Robust and prototypical immune responses toward COVID-19 vaccine in First Nations peoples are impacted by comorbidities"],"prefix":"10.1038","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7460-4956","authenticated-orcid":false,"given":"Wuji","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0203-1057","authenticated-orcid":false,"given":"Lukasz","family":"Kedzierski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brendon Y.","family":"Chua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Mayo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Lonzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa","family":"Rigas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bianca F.","family":"Middleton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7089-5300","authenticated-orcid":false,"given":"Hayley A.","family":"McQuilten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise C.","family":"Rowntree","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lilith F.","family":"Allen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6378-5114","authenticated-orcid":false,"given":"Ruth A.","family":"Purcell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1064-3934","authenticated-orcid":false,"given":"Hyon-Xhi","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Petersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3755-159X","authenticated-orcid":false,"given":"Priyanka","family":"Chaurasia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3754-2642","authenticated-orcid":false,"given":"Francesca","family":"Mordant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikhail V.","family":"Pogorelyy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastasia A.","family":"Minervina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4096-6048","authenticated-orcid":false,"given":"Jeremy Chase","family":"Crawford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8559-5872","authenticated-orcid":false,"given":"Griffith B.","family":"Perkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7416-038X","authenticated-orcid":false,"given":"Stephanie","family":"Gras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. Bridie","family":"Clemens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9072-1017","authenticated-orcid":false,"given":"Jennifer A.","family":"Juno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Audsley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2663-1551","authenticated-orcid":false,"given":"David S.","family":"Khoury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natasha E.","family":"Holmes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irani","family":"Thevarajan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanta","family":"Subbarao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4121-776X","authenticated-orcid":false,"given":"Florian","family":"Krammer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allen C.","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4751-1831","authenticated-orcid":false,"given":"Miles P.","family":"Davenport","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Branka","family":"Grubor-Bauk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. Toby","family":"Coates","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Britt","family":"Christensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7955-0256","authenticated-orcid":false,"given":"Paul G.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5593-9387","authenticated-orcid":false,"given":"Adam K.","family":"Wheatley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8539-4891","authenticated-orcid":false,"given":"Stephen J.","family":"Kent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2020-7522","authenticated-orcid":false,"given":"Jamie","family":"Rossjohn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0020-9704","authenticated-orcid":false,"given":"Amy W.","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Boffa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Lynar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane","family":"Nelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9294-7693","authenticated-orcid":false,"given":"Thi H. O.","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3843-837X","authenticated-orcid":false,"given":"Jane","family":"Davies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6141-335X","authenticated-orcid":false,"given":"Katherine","family":"Kedzierska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,5,29]]},"reference":[{"key":"1508_CR1","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/S0140-6736(20)31682-2","volume":"396","author":"The Lancet","year":"2020","unstructured":"The Lancet Self-determination and Indigenous health. Lancet 396, 361 (2020).","journal-title":"Lancet"},{"key":"1508_CR2","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1016\/S0140-6736(20)31104-1","volume":"395","author":"HS Kaplan","year":"2020","unstructured":"Kaplan, H. S. et al. Voluntary collective isolation as a best response to COVID-19 for indigenous populations? A case study and protocol from the Bolivian Amazon. Lancet 395, 1727\u20131734 (2020).","journal-title":"Lancet"},{"key":"1508_CR3","doi-asserted-by":"crossref","unstructured":"Arias, E., Tejada-Vera, B., Kochanek, K. D. & Ahmad, F. B. Provisional Life Expectancy Estimates for 2021. Vital Statistics Rapid Release Report No. 23 (National Center for Health Statistics, 2022).","DOI":"10.15620\/cdc:118999"},{"key":"1508_CR4","doi-asserted-by":"publisher","first-page":"e004655","DOI":"10.1136\/bmjgh-2020-004655","volume":"6","author":"A Mallard","year":"2021","unstructured":"Mallard, A., Pesantes, M. A., Zavaleta-Cortijo, C. & Ward, J. An urgent call to collect data related to COVID-19 and Indigenous populations globally. BMJ Glob. Health 6, e004655 (2021).","journal-title":"BMJ Glob. Health"},{"key":"1508_CR5","first-page":"1","volume":"68","author":"K Kochanek","year":"2019","unstructured":"Kochanek, K., Murphy, S., Xu, J. & Arias, E. Deaths: final data for 2017. Natl Vital Stat. Rep. 68, 1\u201377 (2019).","journal-title":"Natl Vital Stat. Rep."},{"key":"1508_CR6","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.5588\/ijtld.12.0385","volume":"17","author":"D Tollefson","year":"2013","unstructured":"Tollefson, D. et al. Burden of tuberculosis in indigenous peoples globally: a systematic review. Int. J. Tuberc. Lung Dis. 17, 1139\u20131150 (2013).","journal-title":"Int. J. Tuberc. Lung Dis."},{"key":"1508_CR7","doi-asserted-by":"publisher","first-page":"519","DOI":"10.5694\/j.1326-5377.2011.tb03088.x","volume":"194","author":"JS Davis","year":"2011","unstructured":"Davis, J. S. et al. Sepsis in the tropical Top End of Australia\u2019s Northern Territory: disease burden and impact on Indigenous Australians. Med. J. Aust. 194, 519\u2013524 (2011).","journal-title":"Med. J. Aust."},{"key":"1508_CR8","first-page":"E482","volume":"40","author":"J Li-Kim-Moy","year":"2016","unstructured":"Li-Kim-Moy, J. et al. Australian vaccine preventable disease epidemiological review series: influenza 2006 to 2015. Commun. Dis. Intell. Q Rep. 40, E482\u2013E495 (2016).","journal-title":"Commun. Dis. Intell. Q Rep."},{"key":"1508_CR9","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1071\/MA11036","volume":"32","author":"P Markey","year":"2011","unstructured":"Markey, P., Su, J.-Y., Wattiaux, A., Trauer, J. & Krause, V. H1N1 2009 pandemic influenza in Indigenous Australians. Microbiol. Aust. 32, 36\u201338 (2011).","journal-title":"Microbiol. Aust."},{"key":"1508_CR10","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1590\/S1806-37132012000100009","volume":"38","author":"L Lenzi","year":"2012","unstructured":"Lenzi, L., Mello, \u00c2. M., Silva, L. R., Grochocki, M. H. & Pontarolo, R. Pandemic influenza A (H1N1) 2009: risk factors for hospitalization. J. Bras. Pneumol. 38, 57\u201365 (2012).","journal-title":"J. Bras. Pneumol."},{"key":"1508_CR11","first-page":"1341","volume":"58","author":"Centers for Disease Control and Prevention","year":"2009","unstructured":"Centers for Disease Control and Prevention Deaths related to 2009 pandemic influenza A (H1N1) among American Indian\/Alaska Natives\u201412 states, 2009. MMWR Morb. Mortal. Wkly Rep. 58, 1341\u20131344 (2009).","journal-title":"MMWR Morb. Mortal. Wkly Rep."},{"key":"1508_CR12","doi-asserted-by":"publisher","first-page":"100","DOI":"10.3201\/eid1601.090994","volume":"16","author":"A Verrall","year":"2010","unstructured":"Verrall, A. et al. Hospitalizations for pandemic (H1N1) 2009 among Maori and Pacific Islanders, New Zealand. Emerg. Infect. Dis. 16, 100\u2013102 (2010).","journal-title":"Emerg. Infect. Dis."},{"key":"1508_CR13","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","volume":"383","author":"FP Polack","year":"2020","unstructured":"Polack, F. P. et al. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. N. Engl. J. Med. 383, 2603\u20132615 (2020).","journal-title":"N. Engl. J. Med."},{"key":"1508_CR14","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1038\/s41586-021-03653-6","volume":"595","author":"U Sahin","year":"2021","unstructured":"Sahin, U. et al. BNT162b2 vaccine induces neutralizing antibodies and poly-specific T cells in humans. Nature 595, 572\u2013577 (2021).","journal-title":"Nature"},{"key":"1508_CR15","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/j.cell.2021.12.026","volume":"185","author":"PA Mudd","year":"2022","unstructured":"Mudd, P. A. et al. SARS-CoV-2 mRNA vaccination elicits a robust and persistent T follicular helper cell response in humans. Cell 185, 603\u2013613 (2022).","journal-title":"Cell"},{"key":"1508_CR16","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1038\/s41590-022-01184-4","volume":"23","author":"AA Minervina","year":"2022","unstructured":"Minervina, A. A. et al. SARS-CoV-2 antigen exposure history shapes phenotypes and specificity of memory CD8+ T cells. Nat. Immunol. 23, 781\u2013790 (2022).","journal-title":"Nat. Immunol."},{"key":"1508_CR17","doi-asserted-by":"publisher","first-page":"100562","DOI":"10.1016\/j.xcrm.2022.100562","volume":"3","author":"K Kedzierska","year":"2022","unstructured":"Kedzierska, K. & Thomas, P. G. Count on us: T cells in SARS-CoV-2 infection and vaccination. Cell Rep. Med. 3, 100562 (2022).","journal-title":"Cell Rep. Med."},{"key":"1508_CR18","doi-asserted-by":"publisher","first-page":"abm0829","DOI":"10.1126\/science.abm0829","volume":"374","author":"RR Goel","year":"2021","unstructured":"Goel, R. R. et al. mRNA vaccines induce durable immune memory to SARS-CoV-2 and variants of concern. Science 374, abm0829 (2021).","journal-title":"Science"},{"key":"1508_CR19","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1038\/s41591-020-0913-5","volume":"26","author":"F Amanat","year":"2020","unstructured":"Amanat, F. et al. A serological assay to detect SARS-CoV-2 seroconversion in humans. Nat. Med. 26, 1033\u20131036 (2020).","journal-title":"Nat. Med."},{"key":"1508_CR20","doi-asserted-by":"publisher","first-page":"e1005456","DOI":"10.1371\/journal.ppat.1005456","volume":"12","author":"AE Mahan","year":"2016","unstructured":"Mahan, A. E. et al. Antigen-specific antibody glycosylation is regulated via vaccination. PLoS Pathog. 12, e1005456 (2016).","journal-title":"PLoS Pathog."},{"key":"1508_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/srep07648","volume":"5","author":"J-R Wang","year":"2015","unstructured":"Wang, J.-R. et al. Glycomic signatures on serum IgGs for prediction of postvaccination response. Sci. Rep. 5, 7648 (2015).","journal-title":"Sci. Rep."},{"key":"1508_CR22","doi-asserted-by":"publisher","first-page":"e1355","DOI":"10.1002\/cti2.1355","volume":"10","author":"MR McLean","year":"2021","unstructured":"McLean, M. R. et al. Serological and cellular inflammatory signatures in end-stage kidney disease and latent tuberculosis. Clin. Transl. Immunol. 10, e1355 (2021).","journal-title":"Clin. Transl. Immunol."},{"key":"1508_CR23","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1038\/s41590-022-01274-3","volume":"23","author":"RS Herati","year":"2022","unstructured":"Herati, R. S. et al. PD-1 directed immunotherapy alters Tfh and humoral immune responses to seasonal influenza vaccine. Nat. Immunol. 23, 1183\u20131192 (2022).","journal-title":"Nat. Immunol."},{"key":"1508_CR24","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1038\/s41590-022-01254-7","volume":"23","author":"K Kedzierska","year":"2022","unstructured":"Kedzierska, K. & Nguyen, T. H. O. PD-1 blockade unblocks immune responses to vaccination. Nat. Immunol. 23, 1135\u20131137 (2022).","journal-title":"Nat. Immunol."},{"key":"1508_CR25","doi-asserted-by":"publisher","first-page":"100208","DOI":"10.1016\/j.xcrm.2021.100208","volume":"2","author":"M Koutsakos","year":"2021","unstructured":"Koutsakos, M. et al. Integrated immune dynamics define correlates of COVID-19 severity and antibody responses. Cell Rep. Med. 2, 100208 (2021).","journal-title":"Cell Rep. Med."},{"key":"1508_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-22236-7","volume":"12","author":"KJ Selva","year":"2021","unstructured":"Selva, K. J. et al. Systems serology detects functionally distinct coronavirus antibody features in children and elderly. Nat. Commun. 12, 2037 (2021).","journal-title":"Nat. Commun."},{"key":"1508_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-21444-5","volume":"12","author":"AK Wheatley","year":"2021","unstructured":"Wheatley, A. K. et al. Evolution of immune responses to SARS-CoV-2 in mild-moderate COVID-19. Nat. Commun. 12, 1162 (2021).","journal-title":"Nat. Commun."},{"key":"1508_CR28","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/s41591-020-0819-2","volume":"26","author":"I Thevarajan","year":"2020","unstructured":"Thevarajan, I. et al. Breadth of concomitant immune responses prior to patient recovery: a case report of non-severe COVID-19. Nat. Med. 26, 453\u2013455 (2020).","journal-title":"Nat. Med."},{"key":"1508_CR29","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1016\/j.immuni.2021.04.009","volume":"54","author":"THO Nguyen","year":"2021","unstructured":"Nguyen, T. H. O. et al. CD8+ T cells specific for an immunodominant SARS-CoV-2 nucleocapsid epitope display high naive precursor frequency and TCR promiscuity. Immunity 54, 1066\u20131082 (2021).","journal-title":"Immunity"},{"key":"1508_CR30","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1016\/j.immuni.2022.06.003","volume":"55","author":"LC Rowntree","year":"2022","unstructured":"Rowntree, L. C. et al. SARS-CoV-2-specific T cell memory with common TCR\u03b1\u03b2 motifs is established in unvaccinated children who seroconvert after infection. Immunity 55, 1299\u20131315 (2022).","journal-title":"Immunity"},{"key":"1508_CR31","doi-asserted-by":"publisher","first-page":"24384","DOI":"10.1073\/pnas.2015486117","volume":"117","author":"JR Habel","year":"2020","unstructured":"Habel, J. R. et al. Suboptimal SARS-CoV-2-specific CD8+ T cell response associated with the prominent HLA-A*02:01 phenotype. Proc. Natl Acad. Sci. USA 117, 24384\u201324391 (2020).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1508_CR32","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1038\/s41591-020-01143-2","volume":"27","author":"I Schulien","year":"2021","unstructured":"Schulien, I. et al. Characterization of pre-existing and induced SARS-CoV-2-specific CD8+ T cells. Nat. Med. 27, 78\u201385 (2021).","journal-title":"Nat. Med."},{"key":"1508_CR33","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1111\/imcb.12482","volume":"99","author":"LC Rowntree","year":"2021","unstructured":"Rowntree, L. C. et al. SARS-CoV-2-specific CD8+ T-cell responses and TCR signatures in the context of a prominent HLA-A*24:02 allomorph. Immunol. Cell Biol. 99, 990\u20131000 (2021).","journal-title":"Immunol. Cell Biol."},{"key":"1508_CR34","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1016\/j.immuni.2020.10.006","volume":"53","author":"AP Ferretti","year":"2020","unstructured":"Ferretti, A. P. et al. Unbiased screens show CD8+ T cells of COVID-19 patients recognize shared epitopes in SARS-CoV-2 that largely reside outside the spike protein. Immunity 53, 1095\u20131107 (2020).","journal-title":"Immunity"},{"key":"1508_CR35","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1172\/JCI41538","volume":"120","author":"NL La Gruta","year":"2010","unstructured":"La Gruta, N. L. et al. Primary CTL response magnitude in mice is determined by the extent of naive T cell recruitment and subsequent clonal expansion. J. Clin. Invest. 120, 1885\u20131894 (2010).","journal-title":"J. Clin. Invest."},{"key":"1508_CR36","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1038\/icb.2015.93","volume":"94","author":"EB Clemens","year":"2016","unstructured":"Clemens, E. B. et al. Towards identification of immune and genetic correlates of severe influenza disease in Indigenous Australians. Immunol. Cell Biol. 94, 367\u2013377 (2016).","journal-title":"Immunol. Cell Biol."},{"key":"1508_CR37","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-13346-4","volume":"10","author":"CE van de Sandt","year":"2019","unstructured":"van de Sandt, C. E. et al. Challenging immunodominance of influenza-specific CD8+ T cell responses restricted by the risk-associated HLA-A*68:01 allomorph. Nat. Commun. 10, 5579 (2019).","journal-title":"Nat. Commun."},{"key":"1508_CR38","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/j.immuni.2015.08.012","volume":"43","author":"ZM Ndhlovu","year":"2015","unstructured":"Ndhlovu, Z. M. et al. Magnitude and kinetics of CD8+ T cell activation during hyperacute HIV infection impact viral set point. Immunity 43, 591\u2013604 (2015).","journal-title":"Immunity"},{"key":"1508_CR39","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1016\/j.immuni.2020.11.004","volume":"53","author":"AS Shomuradova","year":"2020","unstructured":"Shomuradova, A. S. et al. SARS-CoV-2 epitopes are recognized by a public and diverse repertoire of human T cell receptors. Immunity 53, 1245\u20131257 (2020).","journal-title":"Immunity"},{"key":"1508_CR40","doi-asserted-by":"publisher","first-page":"2648","DOI":"10.1161\/CIRCULATIONAHA.118.033891","volume":"138","author":"ML Kim","year":"2018","unstructured":"Kim, M. L. et al. Dysregulated IL-1\u03b2-GM-CSF axis in acute rheumatic fever that is limited by hydroxychloroquine. Circulation 138, 2648\u20132661 (2018).","journal-title":"Circulation"},{"key":"1508_CR41","doi-asserted-by":"publisher","first-page":"e73475","DOI":"10.7554\/eLife.73475","volume":"11","author":"ML Russell","year":"2022","unstructured":"Russell, M. L. et al. Combining genotypes and T cell receptor distributions to infer genetic loci determining V(D)J recombination probabilities. eLife 11, e73475 (2022).","journal-title":"eLife"},{"key":"1508_CR42","doi-asserted-by":"publisher","first-page":"e4112","DOI":"10.1097\/MD.0000000000004112","volume":"95","author":"X Yu","year":"2016","unstructured":"Yu, X. et al. Profiling IgG N-glycans as potential biomarker of chronological and biological ages: a community-based study in a Han Chinese population. Medicine 95, e4112 (2016).","journal-title":"Medicine"},{"key":"1508_CR43","doi-asserted-by":"publisher","first-page":"eaan8405","DOI":"10.1126\/scitranslmed.aan8405","volume":"10","author":"M Koutsakos","year":"2018","unstructured":"Koutsakos, M. et al. Circulating TFH cells, serological memory, and tissue compartmentalization shape human influenza-specific B cell immunity. Sci. Transl. Med. 10, eaan8405 (2018).","journal-title":"Sci. Transl. Med."},{"key":"1508_CR44","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1038\/s41591-021-01386-7","volume":"27","author":"EM Bange","year":"2021","unstructured":"Bange, E. M. et al. CD8+ T cells contribute to survival in patients with COVID-19 and hematologic cancer. Nat. Med. 27, 1280\u20131289 (2021).","journal-title":"Nat. Med."},{"key":"1508_CR45","doi-asserted-by":"publisher","first-page":"e1010337","DOI":"10.1371\/journal.ppat.1010337","volume":"18","author":"JR Habel","year":"2022","unstructured":"Habel, J. R. et al. HLA-A*11:01-restricted CD8+ T cell immunity against influenza A and influenza B viruses in Indigenous and non-Indigenous people. PLoS Pathog. 18, e1010337 (2022).","journal-title":"PLoS Pathog."},{"key":"1508_CR46","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-23212-x","volume":"12","author":"L Hensen","year":"2021","unstructured":"Hensen, L. et al. CD8+ T cell landscape in Indigenous and non-Indigenous people restricted by influenza mortality-associated HLA-A*24:02 allomorph. Nat. Commun. 12, 2931 (2021).","journal-title":"Nat. Commun."},{"key":"1508_CR47","unstructured":"Zhao, Y., Zhang, X., Foley, M. & Guthridge, S. Northern Territory Burden of Disease Study: Fatal Burden of Disease and Injury, 2004\u20132013 (Department of Health, 2016)."},{"key":"1508_CR48","unstructured":"Nous Group. Evaluation of the Northern Territory Chronic Conditions Prevention and Management Strategy 2010-2020: Final Report (Northern Territory Department of Health, 2020)."},{"key":"1508_CR49","doi-asserted-by":"publisher","first-page":"e059716","DOI":"10.1136\/bmjopen-2021-059716","volume":"12","author":"MJL Hare","year":"2022","unstructured":"Hare, M. J. L. et al. Prevalence and incidence of diabetes among Aboriginal people in remote communities of the Northern Territory, Australia: a retrospective, longitudinal data-linkage study. BMJ Open 12, e059716 (2022).","journal-title":"BMJ Open"},{"key":"1508_CR50","doi-asserted-by":"publisher","DOI":"10.1186\/s12882-017-0791-3","volume":"19","author":"L Li","year":"2018","unstructured":"Li, L. et al. Estimating the total prevalence and incidence of end-stage kidney disease among Aboriginal and non-Aboriginal populations in the Northern Territory of Australia, using multiple data sources. BMC Nephrol. 19, 15 (2018).","journal-title":"BMC Nephrol."},{"key":"1508_CR51","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2022-329136","author":"E Zhang","year":"2023","unstructured":"Zhang, E. et al. Robust SARS-CoV-2 antibody and T cell immunity following three COVID-19 vaccine doses in inflammatory bowel disease patients receiving anti-TNF or alternative treatments. Gut, https:\/\/doi.org\/10.1136\/gutjnl-2022-329136 (2023).","journal-title":"Gut"},{"key":"1508_CR52","doi-asserted-by":"publisher","first-page":"e1258","DOI":"10.1002\/cti2.1258","volume":"10","author":"LC Rowntree","year":"2021","unstructured":"Rowntree, L. C. et al. Robust correlations across six SARS-CoV-2 serology assays detecting distinct antibody features. Clin. Transl. Immunology 10, e1258 (2021).","journal-title":"Clin. Transl. Immunology"},{"key":"1508_CR53","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-30088-y","volume":"13","author":"W Zhang","year":"2022","unstructured":"Zhang, W. et al. SARS-CoV-2 infection results in immune responses in the respiratory tract and peripheral blood that suggest mechanisms of disease severity. Nat. Commun. 13, 2774 (2022).","journal-title":"Nat. Commun."},{"key":"1508_CR54","doi-asserted-by":"publisher","first-page":"459","DOI":"10.5694\/mja2.50569","volume":"212","author":"L Caly","year":"2020","unstructured":"Caly, L. et al. Isolation and rapid sharing of the 2019 novel coronavirus (SARS-CoV-2) from the first patient diagnosed with COVID-19 in Australia. Med. J. Aust. 212, 459\u2013462 (2020).","journal-title":"Med. J. Aust."},{"key":"1508_CR55","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1038\/s41590-021-01077-y","volume":"23","author":"A Di Pietro","year":"2022","unstructured":"Di Pietro, A. et al. Targeting BMI-1 in B cells restores effective humoral immune responses and controls chronic viral infection. Nat. Immunol. 23, 86\u201398 (2022).","journal-title":"Nat. Immunol."},{"key":"1508_CR56","doi-asserted-by":"publisher","first-page":"4440","DOI":"10.1073\/pnas.1603106113","volume":"113","author":"SA Valkenburg","year":"2016","unstructured":"Valkenburg, S. A. et al. Molecular basis for universal HLA-A*0201-restricted CD8+ T-cell immunity against influenza viruses. Proc. Natl Acad. Sci. USA 113, 4440\u20134445 (2016).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1508_CR57","doi-asserted-by":"publisher","first-page":"e134","DOI":"10.1038\/cti.2017.4","volume":"6","author":"TH Nguyen","year":"2017","unstructured":"Nguyen, T. H. et al. Understanding CD8+ T-cell responses toward the native and alternate HLA-A\u221702:01-restricted WT1 epitope. Clin. Transl. Immunology 6, e134 (2017).","journal-title":"Clin. Transl. Immunology"},{"key":"1508_CR58","unstructured":"Brunson, J. C. & Read, Q. D. ggalluvial: Alluvial Plots in \u2018ggplot2\u2019. R package version 0.12.3 https:\/\/cran.r-project.org\/web\/packages\/ggalluvial\/index.html#:~:text=ggalluvial%3A%20Alluvial%20Plots%20in%20'ggplot2,%3Cdoi%3A10.1109%2FINFVIS (2020)."},{"key":"1508_CR59","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/nature22383","volume":"547","author":"P Dash","year":"2017","unstructured":"Dash, P. et al. Quantifiable predictive features define epitope-specific T cell receptor repertoires. Nature 547, 89\u201393 (2017).","journal-title":"Nature"},{"key":"1508_CR60","doi-asserted-by":"publisher","first-page":"e68605","DOI":"10.7554\/eLife.68605","volume":"10","author":"K Mayer-Blackwell","year":"2021","unstructured":"Mayer-Blackwell, K. et al. TCR meta-clonotypes for biomarker discovery with tcrdist3 enabled identification of public, HLA-restricted clusters of SARS-CoV-2 TCRs. eLife 10, e68605 (2021).","journal-title":"eLife"},{"key":"1508_CR61","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1038\/s41591-020-0995-0","volume":"26","author":"JA Juno","year":"2020","unstructured":"Juno, J. A. et al. Humoral and circulating follicular helper T cell responses in recovered patients with COVID-19. Nat. Med. 26, 1428\u20131434 (2020).","journal-title":"Nat. Med."},{"key":"1508_CR62","unstructured":"R Core Team. R: A language and environment for statistical computing (R Foundation for Statistical Computing, 2022)."},{"key":"1508_CR63","unstructured":"Revelle, W. psych: Procedures for psychological, psychometric, and personality research. R package version 2.2.5 https:\/\/CRAN.R-project.org\/package=psych (2022)."},{"key":"1508_CR64","unstructured":"Kassambara, A. rstatix: Pipe-friendly framework for basic statistical tests. R package version 0.7.0 https:\/\/cran.r-project.org\/web\/packages\/rstatix\/index.html (2021)."},{"key":"1508_CR65","unstructured":"Wei, T. & Simko, V. corrplot: Visualization of a correlation matrix. R package version 0.92 https:\/\/cran.r-project.org\/web\/packages\/corrplot\/corrplot.pdf (2021)."},{"key":"1508_CR66","unstructured":"Blighe, K., Rana, S. & Lewis, M. EnhancedVolcano: Publication-ready volcano plots with enhanced colouring and labeling. R package version 1.14.0 https:\/\/bioconductor.org\/packages\/devel\/bioc\/vignettes\/EnhancedVolcano\/inst\/doc\/EnhancedVolcano.html (2022)."}],"container-title":["Nature Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41590-023-01508-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41590-023-01508-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41590-023-01508-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,31]],"date-time":"2023-05-31T12:13:51Z","timestamp":1685535231000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41590-023-01508-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,29]]},"references-count":66,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["1508"],"URL":"https:\/\/doi.org\/10.1038\/s41590-023-01508-y","relation":{},"ISSN":["1529-2908","1529-2916"],"issn-type":[{"value":"1529-2908","type":"print"},{"value":"1529-2916","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,29]]},"assertion":[{"value":"29 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The Icahn School of Medicine at Mount Sinai has filed patent applications relating to SARS-CoV-2 serological assays and Newcastle disease virus-based SARS-CoV-2 vaccines that list F.K. as coinventor. Mount Sinai has spun out a company, Kantaro, to market serological tests for SARS-CoV-2. F.K. has consulted for Merck and Pfizer (before 2020), and is currently consulting for Pfizer, CSL Seqirus and Avimex. The Krammer laboratory is also collaborating with Pfizer on animal models of SARS-CoV-2. H.A.M. is currently consulting for ENA Respiratory. P.T. is on the scientific advisory board of ImmunoScape and CytoAgents and has consulted for Johnson & Johnson. P.T. has received travel support and honoraria from Illumina and 10X Genomics and has patents related to TCR discovery and expression. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}